BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 35932567)

  • 1. An auristatin-based peptide-drug conjugate targeting Kita-Kyushu lung cancer antigen 1 for precision chemoradiotherapy in gastric cancer.
    Chen X; Liu F; Yu X; Li L; Yan J; Chen X; Liu Q; Liu B
    Eur J Med Chem; 2022 Nov; 241():114617. PubMed ID: 35932567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Precision Chemoradiotherapy for HER2 Tumors Using Antibody Conjugates of an Auristatin Derivative with Reduced Cell Permeability.
    Hingorani DV; Doan MK; Camargo MF; Aguilera J; Song SM; Pizzo D; Scanderbeg DJ; Cohen EEW; Lowy AM; Adams SR; Advani SJ
    Mol Cancer Ther; 2020 Jan; 19(1):157-167. PubMed ID: 31597712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequent High Expression of Kita-Kyushu Lung Cancer Antigen-1 (KK-LC-1) in Gastric Cancer.
    Shida A; Futawatari N; Fukuyama T; Ichiki Y; Takahashi Y; Nishi Y; Kobayashi N; Yamazaki H; Watanabe M
    Anticancer Res; 2015 Jun; 35(6):3575-9. PubMed ID: 26026129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor radiosensitization by monomethyl auristatin E: mechanism of action and targeted delivery.
    Buckel L; Savariar EN; Crisp JL; Jones KA; Hicks AM; Scanderbeg DJ; Nguyen QT; Sicklick JK; Lowy AM; Tsien RY; Advani SJ
    Cancer Res; 2015 Apr; 75(7):1376-1387. PubMed ID: 25681274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of Kita-Kyushu Lung Cancer Antigen-1 as Detected by a Novel Monoclonal Antibody in Gastric Cancer.
    Takahashi Y; Fukuyama T; Futawatari N; Ichiki Y; Ohmiya H; Chuman M; Yamashita T; Hiki N; Kumamoto Y; Yamazaki H; Nonoguchi H; Nishi Y; Kobayashi N
    Anticancer Res; 2019 Nov; 39(11):6259-6263. PubMed ID: 31704855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer targeting by TCR gene-engineered T cells directed against Kita-Kyushu Lung Cancer Antigen-1.
    Marcinkowski B; Stevanović S; Helman SR; Norberg SM; Serna C; Jin B; Gkitsas N; Kadakia T; Warner A; Davis JL; Rooper L; Hinrichs CS
    J Immunother Cancer; 2019 Aug; 7(1):229. PubMed ID: 31455429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted Chemoradiotherapy of Prostate Cancer Using Gold Nanoclusters with Protease Activatable Monomethyl Auristatin E.
    Luo D; Wang X; Walker E; Springer S; Ramamurthy G; Burda C; Basilion JP
    ACS Appl Mater Interfaces; 2022 Apr; 14(13):14916-14927. PubMed ID: 35316026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a peptide binding to cancer antigen Kita-kyushu lung cancer antigen 1 from a phage-display library.
    Yu X; Yan J; Chen X; Wei J; Yu L; Liu F; Li L; Liu B
    Cancer Sci; 2021 Oct; 112(10):4335-4345. PubMed ID: 34387029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An auristatin-based antibody-drug conjugate targeting HER3 enhances the radiation response in pancreatic cancer.
    Bourillon L; Bourgier C; Gaborit N; Garambois V; Llès E; Zampieri A; Ogier C; Jarlier M; Radosevic-Robin N; Orsetti B; Delpech H; Theillet C; Colombo PE; Azria D; Pèlegrin A; Larbouret C; Chardès T
    Int J Cancer; 2019 Oct; 145(7):1838-1851. PubMed ID: 30882895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer/testis antigen, Kita-Kyushu lung cancer antigen-1 and ABCD stratification for diagnosing gastric cancers.
    Shida A; Fukuyama T; Futawatari N; Ohmiya H; Ichiki Y; Yamashita T; Nishi Y; Kobayashi N; Yamazaki H; Watanabe M; Takahashi Y
    World J Gastroenterol; 2020 Jan; 26(4):424-432. PubMed ID: 32063691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and anti-cancer evaluation of promiximab-MMAE, an anti-CD56 antibody drug conjugate, in small cell lung cancer cell line xenograft models.
    Yu L; Yao Y; Wang Y; Zhou S; Lai Q; Lu Y; Liu Y; Zhang R; Wang R; Liu C; Gou L; Chen X; Yu Y; Chen Q; Yang J
    J Drug Target; 2018 Dec; 26(10):905-912. PubMed ID: 29630426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A glypican-1-targeted antibody-drug conjugate exhibits potent tumor growth inhibition in glypican-1-positive pancreatic cancer and esophageal squamous cell carcinoma.
    Munekage E; Serada S; Tsujii S; Yokota K; Kiuchi K; Tominaga K; Fujimoto M; Kanda M; Uemura S; Namikawa T; Nomura T; Murakami I; Hanazaki K; Naka T
    Neoplasia; 2021 Sep; 23(9):939-950. PubMed ID: 34332450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Novel Anti-CD22 Anthracycline-Based Antibody-Drug Conjugate (ADC) That Overcomes Resistance to Auristatin-Based ADCs.
    Yu SF; Zheng B; Go M; Lau J; Spencer S; Raab H; Soriano R; Jhunjhunwala S; Cohen R; Caruso M; Polakis P; Flygare J; Polson AG
    Clin Cancer Res; 2015 Jul; 21(14):3298-306. PubMed ID: 25840969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An antibody-drug conjugate targeting a GSTA glycosite-signature epitope of MUC1 expressed by non-small cell lung cancer.
    Pan D; Tang Y; Tong J; Xie C; Chen J; Feng C; Hwu P; Huang W; Zhou D
    Cancer Med; 2020 Dec; 9(24):9529-9540. PubMed ID: 33084221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody-drug conjugates with HER2-targeting antibodies from synthetic antibody libraries are highly potent against HER2-positive human gastric tumor in xenograft models.
    Kuo WY; Hsu HJ; Wu CY; Chen HS; Chou YC; Tsou YL; Peng HP; Jian JW; Yu CM; Chiu YK; Chen IC; Tung CP; Hsiao M; Lin CL; Wang YA; Wang AH; Yang AS
    MAbs; 2019 Jan; 11(1):153-165. PubMed ID: 30365359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation Between Expression of the Cancer/Testis Antigen KK-LC-1 and
    Fukuyama T; Futawatari N; Ichiki Y; Shida A; Yamazaki T; Nishi Y; Nonoguchi H; Takahashi Y; Yamazaki H; Kobayashi N
    In Vivo; 2017; 31(3):403-407. PubMed ID: 28438869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monomethyl auristatin E-conjugated anti-EGFR antibody inhibits the growth of human EGFR-positive non-small cell lung cancer.
    Li Z; Wang M; Yu D; Luo W; Fang J; Huang C; Yao X
    Cancer Chemother Pharmacol; 2019 Jul; 84(1):61-72. PubMed ID: 31037333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HER2-targeted antibody drug conjugates for ovarian cancer therapy.
    Jiang J; Dong L; Wang L; Wang L; Zhang J; Chen F; Zhang X; Huang M; Li S; Ma W; Xu Q; Huang C; Fang J; Wang C
    Eur J Pharm Sci; 2016 Oct; 93():274-86. PubMed ID: 27509865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and biological assessment of MMAE-trastuzumab antibody-drug conjugates (ADCs).
    Yaghoubi S; Gharibi T; Karimi MH; Sadeqi Nezhad M; Seifalian A; Tavakkol R; Bagheri N; Dezhkam A; Abdollahpour-Alitappeh M
    Breast Cancer; 2021 Jan; 28(1):216-225. PubMed ID: 32889587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Conjugate Based on Anti-HER2 Diaffibody and Auristatin E Targets HER2-Positive Cancer Cells.
    Serwotka-Suszczak AM; Sochaj-Gregorczyk AM; Pieczykolan J; Krowarsch D; Jelen F; Otlewski J
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28216573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.